Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression analysis of T-ALL cell lines treated with gamma-secretase inhibitor

ABSTRACT: Gain-of-function mutations in NOTCH1 are common in T-cell lymphoblastic leukemias making this receptor a promising target for drugs such as gamma-secretase inhibitors (GSI), which block a proteolytic cleavage required for NOTCH1 activation. However, the enthusiasm for these therapies has been tempered by tumor resistance and the paucity of information on the oncogenic programs regulated by oncogenic NOTCH1. Analysis of gene expression in GSI-responsive and GSI-resistant cell lines treated with Compound E identifies differential resopnses to GSI. Keywords: Drug response Samples for microarray analysis were prepared and hybridized in Affymetrix Human U133 Plus 2.0 arrays according to the manufacturer’s instructions and as previously described. RNA was extracted from duplicate cultures of GSI-sensitive (ALL-SIL, CUTLL1, DND41, HPB-ALL, KOPTK1) and GSI-resistant (CCRF-CEM, MOLT3, P12 ICHIKAWA, PF382 and RPMI8402) T-ALL cell lines treated for 24 h with vehicle (DMSO) or 500 nM CompE. Interarray intensity differences were normalized with Dchip.

ORGANISM(S): Homo sapiens

SUBMITTER: Adolfo Ferrando 

PROVIDER: E-GEOD-5716 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Gain-of-function mutations in NOTCH1 are common in T-cell lymphoblastic leukemias and lymphomas (T-ALL), making this receptor a promising target for drugs such as gamma-secretase inhibitors, which block a proteolytic cleavage required for NOTCH1 activation. However, the enthusiasm for these therapies has been tempered by tumor resistance and the paucity of information on the oncogenic programs regulated by oncogenic NOTCH1. Here we show that NOTCH1 regulates the expression of PTEN (encoding phos  ...[more]

Similar Datasets

Transcriptomics Human T-ALL cell line response to inhibition of Notch signaling
2011-07-31 | E-GEOD-29959 | biostudies-arrayexpress
Transcriptomics Transcription profiling of human gamma-secretase inhibitor-sensitive and -resistant T-ALL cell lines
2008-06-14 | E-GEOD-5682 | biostudies-arrayexpress
Transcriptomics Discovery of biomarkers predictive of GSI response in triple negative breast cancer and adenoid cystic carcinoma
2014-08-14 | E-GEOD-59810 | biostudies-arrayexpress
Transcriptomics Preclinical analysis of the gamma secretase inhibitor PF-030840214 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia
2011-11-09 | E-GEOD-33562 | biostudies-arrayexpress
Genomics NOTCH1/RBPJ complexes drive target gene expression through dynamic interactions with super-enhancers
2013-12-27 | E-GEOD-51800 | biostudies-arrayexpress
Transcriptomics Transcription profiling of human T-ALL cell cultures treated with Compound E, a gamma-secretase inhibitor or vehicle only (DMSO) for 24 h
2008-06-14 | E-GEOD-5827 | biostudies-arrayexpress
Transcriptomics Gamma-secretase inhibitor plus fludarabine in CLL
2013-09-21 | E-GEOD-51044 | biostudies-arrayexpress
Transcriptomics Gene expression analysis of T-ALL cell lines treated with gamma-secretase inhibitor
2008-08-20 | GSE5716 | GEO
Transcriptomics Gamma-secretase inhibitor plus fludarabine in CLL
2013-09-21 | GSE51044 | GEO
Transcriptomics Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq]
2018-03-20 | GSE90715 | GEO